http://www.pediatriclinx.com/thearts.cfm?artid=428582&specid=6&ok=yes
|
|
|
|
|
|
|
|
|
|
| Article Abstract |
 |
 |
 |
 |
 |
Online ISSN: 1097-0142 Print ISSN: 0008-543X Copyright © 2002 American Cancer Society |
|
Original Article
| Parental medication use and risk of childhood acute lymphoblastic leukemia |
Wanqing Wen, M.D. 1, Xiao Ou Shu,
M.D., Ph.D. 1 * ,
John D. Potter, M.D., Ph.D. 2, Richard K.
Severson, Ph.D. 3, Jonathan D. Buckley,
M.D., Ph.D. 4, Gregory H. Reaman, M.D.
5, Leslie L. Robison, Ph.D. 6 |
| 1Department of Medicine, School of
Medicine, Vanderbilt University, Nashville, Tennessee 2Division of Public Health Science, Fred Hutchinson Cancer Research Center, Seattle, Washington 3Karmanos Cancer Institute, Detroit, Michigan 4School of Medicine, University of Southern California, Los Angeles, California 5Department of Pediatric Hematology/Oncology, Children's National Medical Canter, Washington, DC 6Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota |
| email: Xiao Ou Shu (Xiao-Ou.Shu@mcmail.vanderbilt.edu) |
*Correspondence to Xiao Ou Shu, Department of Medicine, Vanderbilt Children's Hospital, 6th Floor, Medical Center East, Room 6009, Nashville, TN 37232-8300
Fax: (615) 936-1269
Funded by:
National Cancer Institute; Grant Number: CA
49450, CA 13539
National Institutes of Health
Department of Health and Human Services
Children's Cancer Research Fund
| Keywords |
| medication • child • acute lymphoblastic leukemia |
| Abstract |
BACKGROUND |
| Few studies have examined the risk of childhood acute lymphoblastic leukemia (ALL) associated with parental medication use. As part of a large case-control study conducted by the Children's Cancer Group, we evaluated the association between maternal and paternal medication use and the risk of ALL in offspring. |
METHODS |
| Information on selected medication use in the year before and during the index pregnancy was obtained by telephone interview. Participants included 1842 children of 14 years or younger with newly diagnosed and immunophenotypically defined ALL and 1986 individually matched controls. Data were analyzed using logistic regression models and stratified by immunophenotypes of ALL and age at diagnosis of cases. |
RESULTS |
| After adjusting for potential confounders and other medication use, we found that maternal use of vitamins (odds ratio [OR] = 0.7, 99% confidence interval [CI]: 0.5-1.0) and iron supplements (OR = 0.8, 99% CI: 0.7-1.0) only during the index pregnancy was associated with a decreased risk of ALL. Parental use of amphetamines or diet pills and mind-altering drugs before and during the index pregnancy was related to an increased risk of childhood ALL, particularly among children where both parents reported using these drugs (OR = 2.8, 99% CI: 0.5-15.6 for amphetamines or diet pills, OR = 1.8, 99% CI: 1.1-3.0 for mind-altering drugs). Stratified analyses showed that maternal use of antihistamines or allergic remedies and parental use of mind-altering drugs were strongly associated with infant ALL, whereas patterns of association between childhood ALL and parental medication use did not influence markedly the immunophenotypic subgroup of ALL. |
CONCLUSIONS |
| The findings of this study suggest that certain parental medication use immediately before and during the index pregnancy may influence risk of ALL in offspring. Cancer 2002;95:1786-94. © 2002 American Cancer Society. |
| DOI 10.1002/cncr.10859 |
Received: 23 October 2001; Revised: 14 May 2002; Accepted: 20 May 2002
| Digital Object Identifier (DOI) |
10.1002/cncr.10859 About
DOI
| References are available in the Enhanced Abstract |
Additional Information
 |
Wiley InterScience is a member of CrossRef
Copyright © 1999-2002 by
John Wiley & Sons, Inc. All rights reserved.
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.
